These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 26931135)

  • 21. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice.
    Camporez JP; Petersen MC; Abudukadier A; Moreira GV; Jurczak MJ; Friedman G; Haqq CM; Petersen KF; Shulman GI
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2212-7. PubMed ID: 26858428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia's ageing population?
    Scott D; de Courten B; Ebeling PR
    Med J Aust; 2016 Oct; 205(7):329-33. PubMed ID: 27681976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcopenic Obesity and Amino Acids: Concord Health and Ageing in Men Project.
    Le Couteur DG; Handelsman DJ; Stanaway F; Waite LM; Blyth FM; Naganathan V; Cumming RG; Hirani V
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1000-1004. PubMed ID: 33709116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcopenia, frailty and type 2 diabetes mellitus (Review).
    Nishikawa H; Fukunishi S; Asai A; Yokohama K; Ohama H; Nishiguchi S; Higuchi K
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
    Lee J; Hong YP; Shin HJ; Lee W
    J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sarcopenia: characteristics, mechanisms and functional significance.
    Narici MV; Maffulli N
    Br Med Bull; 2010; 95():139-59. PubMed ID: 20200012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Exercise and Nutrition in the Prevention of Sarcopenia.
    Makanae Y; Fujita S
    J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S125-7. PubMed ID: 26598823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of obesity and type 2 diabetes on protein anabolic response to insulin in elderly women.
    Murphy J; Chevalier S; Gougeon R; Goulet ÉD; Morais JA
    Exp Gerontol; 2015 Sep; 69():20-6. PubMed ID: 26068615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.
    Batsis JA; Villareal DT
    Nat Rev Endocrinol; 2018 Sep; 14(9):513-537. PubMed ID: 30065268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review.
    Dowling L; Duseja A; Vilaca T; Walsh JS; Goljanek-Whysall K
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):68-85. PubMed ID: 34984856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogen Sulfide Donor NaHS Improves Metabolism and Reduces Muscle Atrophy in Type 2 Diabetes: Implication for Understanding Sarcopenic Pathophysiology.
    Bitar MS; Nader J; Al-Ali W; Al Madhoun A; Arefanian H; Al-Mulla F
    Oxid Med Cell Longev; 2018; 2018():6825452. PubMed ID: 30510624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glucose metabolism in older patients].
    Laurentius T; Freitag M; Eitner J; Eisert A; Bertsch T; Bollheimer LC
    Internist (Berl); 2019 Feb; 60(2):133-140. PubMed ID: 30617701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcopenia and sarcopenic obesity.
    Choi KM
    Korean J Intern Med; 2016 Nov; 31(6):1054-1060. PubMed ID: 27809450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys.
    Kim YS; Lee Y; Chung YS; Lee DJ; Joo NS; Hong D; Song Ge; Kim HJ; Choi YJ; Kim KM
    J Gerontol A Biol Sci Med Sci; 2012 Oct; 67(10):1107-13. PubMed ID: 22431554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation.
    Guillet C; Masgrau A; Walrand S; Boirie Y
    Obes Rev; 2012 Dec; 13 Suppl 2():51-7. PubMed ID: 23107259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frailty and muscle metabolism dysregulation in the elderly.
    Evans WJ; Paolisso G; Abbatecola AM; Corsonello A; Bustacchini S; Strollo F; Lattanzio F
    Biogerontology; 2010 Oct; 11(5):527-36. PubMed ID: 20683658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
    Chen WY; Chen CJ; Liu CH; Mao FC
    Diabetes Obes Metab; 2009 Apr; 11(4):293-303. PubMed ID: 18721257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Myogenic and Protein Turnover Signaling in Skeletal Muscle of Chronic Obstructive Pulmonary Disease Patients With Sarcopenia.
    Kneppers AEM; Langen RCJ; Gosker HR; Verdijk LB; Cebron Lipovec N; Leermakers PA; Kelders MCJM; de Theije CC; Omersa D; Lainscak M; Schols AMWJ
    J Am Med Dir Assoc; 2017 Jul; 18(7):637.e1-637.e11. PubMed ID: 28578881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of physical activity with sarcopenia and sarcopenic obesity in community-dwelling older adults: the Fourth Korea National Health and Nutrition Examination Survey.
    Ryu M; Jo J; Lee Y; Chung YS; Kim KM; Baek WC
    Age Ageing; 2013 Nov; 42(6):734-40. PubMed ID: 23761456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.